Worldwide Transdermal Drug Delivery System Industry to 2027 - Strategic Activities by Manufacturers Presents Opportunities
29 sept. 2020 08h39 HE
|
Research and Markets
Dublin, Sept. 29, 2020 (GLOBE NEWSWIRE) -- The "Transdermal Drug Delivery System Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type; Application; End User; and Geography" report...
ChemioCare Announces Addition of Chief Medical Advisor and Director
01 mai 2018 10h00 HE
|
ChemioCare
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a biotech company focused on transforming chemotherapy induced nausea and vomiting (CINV) outcomes...
Transdermal Patch Delivery Technologies Will Create New Blockbuster Drugs
25 mars 2014 07h30 HE
|
Lux Research
BOSTON, MA--(Marketwired - Mar 25, 2014) - Driven by convergence with other platform-enhancing technologies and shifting demographics, transdermal delivery of drugs (through the skin) is poised for...
Vyteris and Zealand Pharma Announce Agreement on Active Transdermal Patch for Peptide Drugs
14 avr. 2009 08h00 HE
|
Vyteris, Inc.
FAIR LAWN, NJ--(Marketwire - April 14, 2009) - Vyteris, Inc. (OTCBB: VYTR), developer of the
first FDA-approved active transdermal drug delivery system and a leader in
active transdermal drug...